Accendra Health, Inc. (ACH)
NYSE: ACH · Real-Time Price · USD
2.800
-0.030 (-1.06%)
May 26, 2026, 2:31 PM EDT - Market open
Accendra Health Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Accendra Health stock has a consensus rating of "Hold" and an average price target of $4.49. The average 1-year stock price forecast is 60.36% higher than the current stock price, while the lowest is $2.70 (-3.57%) and the highest is $6.00 (+114.29%).
Price Target: $4.49 (+60.36%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Accendra Health stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 2 | 1 | 2 | 2 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 5 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Reiterates $3 → $4.5 | Hold | Reiterates | $3 → $4.5 | +60.71% | May 12, 2026 |
| Robert W. Baird | Robert W. Baird | Buy Maintains $5 → $6 | Buy | Maintains | $5 → $6 | +114.29% | May 12, 2026 |
| Citi | Citi | Buy Reiterates $3.25 → $5 | Buy | Reiterates | $3.25 → $5 | +78.57% | May 12, 2026 |
| Bank of America Securities | Bank of America Securities | Sell Reiterates $2.25 | Sell | Reiterates | $2.25 | -19.64% | Apr 1, 2026 |
Financial Forecast
Revenue This Year
2.60B
from 2.76B
Decreased by -5.83%
Revenue Next Year
2.71B
from 2.60B
Increased by 4.23%
EPS This Year
0.42
from -14.32
EPS Next Year
0.70
from 0.42
Increased by 64.64%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 2.7B | 3.0B | ||
| Avg | 2.6B | 2.7B | ||
| Low | 2.5B | 2.5B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | -0.6% | 14.0% | ||
| Avg | -5.8% | 4.2% | ||
| Low | -10.1% | -3.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 0.72 | 1.42 | |||
| Avg | 0.42 | 0.70 | |||
| Low | 0.25 | 0.31 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | 235.4% | |||
| Avg | - | 64.6% | |||
| Low | - | -25.8% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.